Gofen & Glossberg’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-11,884
| Closed | -$256K | – | 451 |
|
|
2018
Q3 | $256K | Sell |
11,884
-5,570
| -32% | -$120K | 0.01% | 393 |
|
|
2018
Q2 | $424K | Sell |
17,454
-200
| -1% | -$4.86K | 0.02% | 303 |
|
|
2018
Q1 | $302K | Sell |
17,654
-150
| -0.8% | -$2.57K | 0.01% | 367 |
|
|
2017
Q4 | $337K | Sell |
17,804
-22,071
| -55% | -$418K | 0.01% | 365 |
|
|
2017
Q3 | $702K | Sell |
39,875
-27,776
| -41% | -$489K | 0.03% | 243 |
|
|
2017
Q2 | $2.25M | Sell |
67,651
-20,117
| -23% | -$668K | 0.09% | 162 |
|
|
2017
Q1 | $2.82M | Sell |
87,768
-63,026
| -42% | -$2.02M | 0.11% | 138 |
|
|
2016
Q4 | $5.47M | Sell |
150,794
-22,674
| -13% | -$822K | 0.22% | 97 |
|
|
2016
Q3 | $7.98M | Sell |
173,468
-4,000
| -2% | -$184K | 0.33% | 82 |
|
|
2016
Q2 | $8.91M | Sell |
177,468
-3,891
| -2% | -$195K | 0.37% | 79 |
|
|
2016
Q1 | $9.71M | Sell |
181,359
-7,190
| -4% | -$385K | 0.41% | 77 |
|
|
2015
Q4 | $12.4M | Sell |
188,549
-3,979
| -2% | -$261K | 0.54% | 60 |
|
|
2015
Q3 | $10.9M | Sell |
192,528
-7,880
| -4% | -$445K | 0.49% | 66 |
|
|
2015
Q2 | $11.8M | Buy |
200,408
+4,293
| +2% | +$254K | 0.5% | 61 |
|
|
2015
Q1 | $12.2M | Sell |
196,115
-6,574
| -3% | -$410K | 0.53% | 58 |
|
|
2014
Q4 | $11.7M | Sell |
202,689
-3,213
| -2% | -$185K | 0.5% | 65 |
|
|
2014
Q3 | $11.1M | Sell |
205,902
-15,569
| -7% | -$837K | 0.49% | 65 |
|
|
2014
Q2 | $11.6M | Sell |
221,471
-29,611
| -12% | -$1.55M | 0.51% | 60 |
|
|
2014
Q1 | $12.5M | Sell |
251,082
-28,948
| -10% | -$1.44M | 0.58% | 52 |
|
|
2013
Q4 | $11.2M | Sell |
280,030
-19,423
| -6% | -$779K | 0.53% | 59 |
|
|
2013
Q3 | $11.3M | Sell |
299,453
-27,768
| -8% | -$1.05M | 0.58% | 53 |
|
|
2013
Q2 | $12.8M | Buy |
+327,221
| New | +$12.8M | 0.69% | 44 |
|